Financial anchor year: FY21. Margin and revenue are as filed for FY21. Balance-sheet measures (current ratio, equity financing, days in A/R) use FY20, the latest filing whose balance sheet reconciled as filed. Days cash on hand is FY22, the most recent year that passed the display gate. Every tile below states its own fiscal year; nothing is carried forward or estimated.
The read
A dialysis facility in NJ. It ran an operating surplus of 3.0% in FY21 on $-0.1M of operating revenue. Only a single comparable reporting year is available, so trend context is limited.
Operating margin · FY21
+3.0%
vs dialysis facilities32nd pctl of 7,741
Days cash on hand · FY22
Not available
vs dialysis facilities—
Total operating revenue · FY22
$-0.1M
vs dialysis facilities0th pctl
Total margin · incl. nonoperating · FY21
+3.0%
vs dialysis facilities32nd pctl
Where DIALYSIS 312583 sits among dialysis facilities
Operating margin · FY23 pool · n = 7,741 of 7,741 filed
Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.
One dialysis facilityDIALYSIS 312583dialysis facility median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+3.0% (FY21)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+3.0% (FY21)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
Not reported in this filing
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
0.52× (FY20)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
-92% (FY20)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
34d (FY20)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY20
FY21
FY22
Patient revenue
4,977
2,951
(95)
Total operating revenue
4,977
2,951
(95)
Total operating expenses
4,485
2,862
192
Operating income
492
89
(286)
Operating margin %
+9.9%
+3.0%
+301.1%
Other non-operating, net
11,497
0
0
Net income
11,989
89
(286)
Net income %
+72.8%
+3.0%
+301.1%
HCRIS CMS-265 cost report · $ thousands · FY20–FY23 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding
Trajectory
Cost-report basis · 4 reporting years
Operating margin
Days cash on hand
The county this dialysis facility serves
Location, NJ
Median household income
$136.0K
vs $82.1K US · $59.7K rural median
Poverty rate
5.5%
vs 12.5% US · 14.3% rural median
Uninsured
5.7%
vs 8.6% US · 8.4% rural median
Age 65+
16.6%
vs 16.8% US · 20.6% rural median
Fair or poor health
12.1%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 3.0% of county personal income is Medicare/Medicaid medical benefits; 8.0% arrives as government transfers (BEA, 2022).
The Board Briefing$1,000
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
